Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Debt / NOTE 3/0
-
Market price (% of par)
-
84.15%
-
Total 13F principal
-
$438,704,655
-
Principal change
-
+$438,704,655
-
Total reported market value
-
$324,149,991
-
Number of holders
-
34
-
Value change
-
+$324,143,704
-
Number of buys
-
34
Institutional Holders of HAEMONETICS CORP MASS - NOTE 3/0 as of Q1 2022
As of 31 Mar 2022,
HAEMONETICS CORP MASS - NOTE 3/0 was held by
34 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$438,704,655
in principal (par value) of the bond.
The largest 10 bondholders included
FRANKLIN RESOURCES INC, ADVENT CAPITAL MANAGEMENT /DE/, Kohlberg Kravis Roberts & Co. L.P., AVIVA PLC, Brandywine Global Investment Management, LLC, Apollo Management Holdings, L.P., NN Investment Partners Holdings N.V., OAKTREE CAPITAL MANAGEMENT LP, Aequim Alternative Investments LP, and OSTERWEIS CAPITAL MANAGEMENT INC.
This page lists
35
institutional bondholders reporting positions
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.